Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2008;336:1132 (17 May), doi:10.1136/bmj.39581.436875.94
John Burn, professor of clinical genetics, Newcastle University
john.burn@newcastle.ac.uk
| The first 150 words of the full text of this article appear below. |
The current UK parliamentary debate on amendments to the 1990 Human Fertilisation and Embryology Act (BMJ 2008:336;1089 doi: 10.1136/bmj.39581.373403.DB) has brought to the fore once again the challenging debate between those who argue that all research involving embryonic stem cells is immoral and those who see immense medical potential in this area of research. As a clinical geneticist raised in the Christian tradition and interested in gene hunting and cancer chemoprevention I can claim to offer a dispassionate opinion. As head of the research institute where some of the most controversial work is under way, and having been a signatory to Liam Donaldsons report that recommended that this research should proceed,1 I must declare an interest.
Three aspects of stem cell research in which my Newcastle colleagues have special interest are mitochondrial transplantation, in vitro gamete development, and human admixed embryos. In all cases, legitimate clinical targets may
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?
Read all Rapid Responses